Amendment Letter to Exclusive Patent and Know-How Licence Agreement between pSiOncology Pte Limited, Beijing Med-Pharm Corporation, and pSiMedica Limited

Contract Categories: Intellectual Property › License Agreements
Summary

This amendment letter updates the Exclusive Patent and Know-How Licence Agreement dated October 26, 2005, between pSiOncology Pte Limited (Licensor), Beijing Med-Pharm Corporation (Licensee), and pSiMedica Limited. The changes include modifying certain definitions, extending specific time periods from 90 to 180 days, and clarifying the scope of the entire agreement clause. All other terms of the original licence remain unchanged. The amendments take effect immediately upon signing by the parties.

Read More Arrow
EX-10.1 2 w16897exv10w1.htm LETTER AGREEMENT... exv10w1  

AMENDMENT LETTER TO EXCLUSIVE PATENT
AND KNOW HOW LICENCE
19 January 2006
Beijing Med-Pharm Corporation
600 West Germantown Pike
Suite 400
Plymouth Meeting
PA 19462
USA
Dear Sirs
  Re:   Exclusive Patent and Know How Licence Agreement between pSiOncology Pte Limited (“Licensor”), Beijing Med-Pharm Corporation (“Licensee”) and pSiMedica Limited (“pSiMedica”) dated 26th October 2005 (“the Licence”)
The parties wish to amend the Licence as follows:
1. Clause 1 — Definitions
Sub-clause 1.15
Delete the words “its Associates” after the words “invoiced by the Licensee”.
Sub-clause 1.22
Delete the words “its Associates” after the words “sales between or among Licensee”.
2. Clause 3.2 — Condition Precedent and Clause 6 Milestone Payments
The time period of 90 calendar days referred to twice in clause 3.2 (Condition Precedent) and once in clause 6 (Milestone Payments) shall be extended to 180 calendar days.
3. Clause 23.9 — Entire Agreement
Insert the following wording after the words “confidentiality agreement dated 11 July 2005,”:
“the letter dated 26th October 2005 from pSiMedica addressed to Martyn Greenacre of Beijing Med-Pharm Corporation, referring to Clauses 14.1.2 and 14.1.3 and disclosing patent searches in its appendix,”

 

 

Save for the amendments referred to above, all other provisions of the Licence shall remain unaltered. The amendments provided in this letter shall take immediate effect.
Please confirm your agreement by signing, dating and returning the counterpart of this letter.
Yours faithfully
ROGER BRIMBLECOMBE
Dr. Roger Brimblecombe
Chairman
pSiMedica Limited
Agreed by and on behalf of Beijing Med-Pharm Corporation
Signed: MARTYN GREENACRE

Authorized Signatory
Name: M.D. Greenacre
Dated: Jan. 20 06